Evidence map›Paper›PMID 34575207›Full record

ArticleJournal of clinical medicine2021

Impact of SARS-CoV-2 Lockdown on Glycaemic Control: A Retrospective Observational Cohort Study in a Tertiary Setting.

Stefan Zechmann, Leana Hotz, Stefania Di Gangi, Klaus Baumgartl, Andreas Plate, Eliska Potlukova

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Stefan ZechmannDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0001-5012-0068
Leana HotzFaculty of Medicine, University of Basel, 4001 Basel, Switzerland.
Stefania Di GangiInstitute of Primary Care, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Klaus BaumgartlDepartment of Information and Communications Technology, University Hospital Basel, 4031 Basel, Switzerland.
Andreas PlateInstitute of Primary Care, University and University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0001-6143-5479
Eliska PotlukovaFaculty of Medicine, University of Basel, 4001 Basel, Switzerland.ORCID 0000-0003-4790-8860
University Hospital of Basel · CHUniversity Hospital of Zurich · CHUniversity of Basel · CH

Funding

Division of Internal Medicine, University Hospital Basel. No grant Nr. available.
6 · The paper itself

Abstract

We analysed the effects of Swiss national lockdown due to the COVID-19 pandemic on the glycaemic control in patients with diabetes mellitus. In a retrospective observational cohort study with observation period 16 December 2018-27 July 2020, we included tertiary care patients with diabetes and at least one glycated haemoglobin A1c (HbA1c) measurement before and after the lockdown beginning. Main outcome measure was change in HbA1c after the lockdown. We included 1078 patients (86% diabetes type 2) with a mean HbA1c of 55.63 mmol/mol (7.24%). Glycaemic control was susceptible to seasonal changes with higher mean HbA1c in winter as compared to spring (57.49 mmol/mol (7.41%) vs. 55.52 mmol/mol (7.23%),

Indexed as

COVID-19diabetes mellitusglycaemic controllockdownSARS-CoV-2seasonal variation

Identifiers

PMID34575207
PMCPMC8466167
OpenAlexW3200840509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.